Between-trial heterogeneity in ARDS research

Frontiers Unsuccessful and Successful Clinical Trials in Acute Respiratory Distress Syndrome: Addressing Physiology-Based Gaps

Frontiers Pharmacologic therapies of ARDS: From natural herb to nanomedicine

One-year patient outcomes based on lung morphology in acute respiratory distress syndrome: secondary analysis of LIVE trial, Critical Care

Frontiers Validation of Messenger Ribonucleic Acid Markers Differentiating Among Human Acute Respiratory Distress Syndrome Subgroups in an Ovine Model of Acute Respiratory Distress Syndrome Phenotypes

Advancing precision medicine for acute respiratory distress syndrome - The Lancet Respiratory Medicine

JCM, Free Full-Text

Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - eBioMedicine

Frontiers Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2

Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies

Medicina, Free Full-Text